Antibiotic Resistance


Article Author:
Yacob Habboush


Article Editor:
Nilmarie Guzman


Editors In Chief:
Jessica Snowden
Asif Noor
H Davies


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Trevor Nezwek
Radia Jamil
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Steve Bhimji
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beata Beatty
Nazia Sadiq
Hajira Basit
Phillip Hynes
Tehmina Warsi


Updated:
11/23/2018 10:30:07 AM

Introduction

Recognition of issues related to the use of antibiotics has been present since their early clinical introduction in the 1940s. Since then, the use of antimicrobials and often inappropriate use of these have been increasing. Antibiotic resistance in the United States kills approximately 23,000 patients a year and incurs over $20 billion in additional medical expenses. Antibiotic stewardship was established to combat this trend and was recognized in 1996 to draw attention to the rising incidents in mortality and morbidity associated with inappropriate use of antibiotics. Antimicrobial agents are at least partially responsible for the development of serious infections by Staphylococcus aureus, vancomycin-resistant enterococci, extended-spectrum B-lactamase producing Enterobacteriaceae, and other infectious agents. The focus of the stewardship programs is to improve clinical outcomes, decrease antibiotic resistance, and decrease healthcare costs. In 2007, stewardship programs were nationally recognized and reinforced by the publication of the stewardship guidelines from the Infectious Disease Society of America (IDSA) in association with the Society of Healthcare Epidemiology of America (SHEA). These guidelines were helpful in developing an institutional program to enhance antimicrobial stewardship.[1][2][3]

Antibiotics are powerful drugs that are used to combat once fatal diseases. As with any powerful medication, antibiotics carry a wide range of adverse effects. The appropriate use of such agents has a high beneficiary effect that outweighs the risks. However, once antibiotics are unnecessarily used, patients experience no benefits while their susceptibility to the side effects is still present. Moreover, antibiotics disrupt the composition of the infectious agent, leading to bacterial adaptation or mutations, and in turn, to new strains that are resistant to the current antibiotic regiment. The inappropriate use of antibiotics in one patient might develop a resistant strain that spreads to other patients that do not use antibiotics, which makes this issue a pressing public health problem. In 2015, 30% of the outpatient antibiotics prescribed were unnecessary, with acute respiratory infections holding the highest unnecessary use of antibiotics at 50%..

Function

Antibiotic resistance occurs when bacteria evolve to evade the effect of antibiotics through multiple different mechanisms. Dissemination of antibiotic resistance genes is an ecological and public health concern. Certain bacteria are able to neutralize an antibiotic by altering its component to render it ineffective. Others might be able to export the antibiotics out of the bacteria, and some can modify their outer structure and receptors so that antibiotics cannot attach to them. These mechanisms might lead to some bacteria surviving the use of the specific antibiotic and developing a resistance that can be passed to other bacteria as they multiply. Bacteria also can become resistant through mutation of their genetic material. 

The mechanism of antibiotic resistance is commonly categorized into the following four groups:

  1. Intrinsic resistance: Bacteria might survive an antibiotic due to intrinsic resistance through evolution by changing their structure or components. For example, an antibiotic that affects the wall building mechanism of the bacteria, such as penicillin, cannot affect bacteria that does not have a cell wall.
  2. Acquired resistance: Bacteria can obtain the ability to resist the activity of a particular antimicrobial agent to which it was previously susceptible. Bacteria can acquire resistance through a new genetic mutation that helps the bacterium survive or by getting DNA from a bacterium that already is resistant. An example is Mycobacterium tuberculosis resistance to rifamycin.
  3. Genetic change: Bacterium DNA might change and alter the production of protein, leading to different bacterial components and receptors which render the bacteria unrecognized by the antibiotic. Bacteria sharing the environment might harbor intrinsic genetic determinants of resistance that would alter the genomics of the bacteria. An example is Escherichia coli (E. coli) and Haemophilus influenza resistance to trimethoprim.
  4. DNA transfer: Bacteria can share genetic components with other bacteria and transfer the resistant DNA through a horizontal gene transfer. Usually, bacteria acquire external genetic material through three main stages: (1) transformation (through naked DNA incorporation), (2) transduction (through the process of phagocytosis), and (3) conjugation (through direct contact). An example is Staphylococcus aureus resistance to methicillin (MRSA).

Several organisms are resistant to multiple antibiotics. For example, isolated E. coli and Enterococcus that are inhibited by cefoxitin, ciprofloxacin, or erythromycin are usually resistant to at least one antibiotic and sometimes multiple antibiotic types including macrolides, tetracyclines, beta-lactams, quinolones, sulfonamides, tetracyclines, and rifamycin.

Issues of Concern

In the past, medicine was able to stay ahead of antimicrobial resistance through research and the development of new agents to overcome the different types of resistance patterns; however, with the recent development of vancomycin-resistant enterococci and the new subtypes of methicillin-resistant Staphylococcus aureus, antibiotic resistance is more prevalent and only can be minimized through stewardship. To combat the rising use of antibiotics, medical and public health professionals have to collaborate to reduce the inappropriate use of antibiotics. Physicians will have to balance the risks of not treating or inadequately treating against the risk of antibiotic use regarding adverse effects, drug interactions, cost, and antibiotic resistance. From a clinical perspective, many clinicians may not be highly concerned about their antibiotic prescribing habits since many patients expect to get an antibiotic when they visit a physician for an issue they perceive as bacterial. A didactic educational discussion with the patient is necessary to change the overprescribing phenomenon. Patients should be educated on viral etiology of different infectious disease syndromes in which antibiotics are unnecessary. Prescription of antibiotics in these circumstance is futile, expose the patients to undesirable side effects or drug-drug interactions and increase healthcare cost, in addition to contributing to development of antimicrobial resistance. For instance, a patient with infectious mononucleosis is treated with oral amoxicillin and develops a rash. [4][5]

Antibiotic stewardship aims to provide a guide for the appropriate use of antibiotics. One of the general principles is to manage patients empirically and then tailor antibiotic therapy based on microbiology results. There are multiple strategies a stewardship program can focus on such as educational, antimicrobial formulary restrictions, prospective audit and feedback, computer-assisted notifications, molecular testing technology, application of management guidelines and multidisciplinary strategies. The core components of an antibiotic stewardship program are leadership commitment, accountability, antibiotic expertise, actions to tailor antibiotic use, tracking of antibiotic use, reporting antibiotic use, and educating clinicians on appropriate antibiotic use. 

Clinical Significance

It is important to recognize that the concept of antimicrobial resistance in clinical practice is a relative phenomenon with high complexity. Engaging patients is crucial for a successful antimicrobial stewardship to reduce rates antibiotic resistance. Educating patients on what they can do to keep themselves safe is part of the discussion on improving antibiotic use. This includes raising awareness about the adverse effects of antibiotics as well as the potential consequences of unnecessary antibiotic use. Also, finding different diagnostic tools to help in guiding the antibiotic treatment is highly beneficial, such as the Overlap2 Method, a new initiative to determine the synergic effect of antibiotics on different antimicrobials. Clinical approach to antimicrobial stewardship might differ from outpatient to inpatient settings; however, all share the goal of improving antibiotic use as a core component of fighting antibiotic resistance.[6][7]

Measuring the clinical significance of the antimicrobial stewardship is complicated and can be assessed by clinical and economical outcomes. A recent study compared the use of continuous antibiotics versus intermittent antibiotics to manage bronchiectasis (by assessing the reduction in the frequency and duration of exacerbations) to the risks of managing antibiotic resistance and minimizing side effects demonstrated a lack of high-evidence studies assessing the impact of stewardship programs. Hence, more prospective clinical trials are needed to evaluate the impact of antimicrobial stewardship on clinical outcomes. Outcome measures to utilize are decreased in length of stay, lower readmission rates, and shorten the period to place the patient on proper effective therapy.  On the other hand, economic outcomes provide stronger results showing the benefits of such stewardship programs. Economic outcomes do not only refer to the antimicrobial expenditure, but also include the costs of the drug, microbiology, length of stay, and infectious disease specialists. More significant savings can result from improved clinical outcomes due to decreased length of stay and reduction in complications related to antibiotic use, such as with Clostridium difficile associated disease. 

Enhancing Healthcare Team Outcomes

In 2017, the Joint Commission announced new stewardship standards requiring every hospital in the United States to have a stewardship program. However, many hospitals have yet to adopt these programs, and many institutions fear that smaller hospitals may not have the ability to develop effective stewardship programs. There are a few possible solutions to overcome these barriers such as joining a larger healthcare system to utilize their resources, pooling resources from other hospitals, and facilitating the use of their state's health department resources. Stewardship is a function of a health system which is usually managed by the government to oversee and regulate healthcare. Antimicrobial stewardship programs require a systematic measurement and coordinated interventions between clinicians, infection control preventionists, pharmacists, and informational technology designed to promote the optimal use of antibiotic agents, including their choice, dosing, route, and duration of administration. [8][9]


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Antibiotic Resistance - Questions

Take a quiz of the questions on this article.

Take Quiz
Which of the following statements about streptococcal pharyngitis is true?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
How is drug resistance transferred in most gram-negative bacteria?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
What is the risk of taking an antibiotic when a viral infection is present?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
How did staphylococcus aureus develope resistance to methicillin?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
What is the basic function of antibiotic stewardship?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 32-year-old man presents complaining of a sore throat, headaches, and fatigue. These symptoms started three days ago and have not improved. He has tried over the counter medications with minimal benefits. The patient is requesting a course of an antibiotic as he believes this will help him. What is the next step in this patient's management?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Antibiotic Resistance - References

References

Zhao X,Wang J,Zhu L,Wang J, Field-based evidence for enrichment of antibiotic resistance genes and mobile genetic elements in manure-amended vegetable soils. The Science of the total environment. 2018 Nov 3     [PubMed]
Ghaddar N,Hashemidahaj M,Findlay BL, Access to high-impact mutations constrains the evolution of antibiotic resistance in soft agar. Scientific reports. 2018 Nov 19     [PubMed]
Ragheb MN,Thomason MK,Hsu C,Nugent P,Gage J,Samadpour AN,Kariisa A,Merrikh CN,Miller SI,Sherman DR,Merrikh H, Inhibiting the Evolution of Antibiotic Resistance. Molecular cell. 2018 Nov 8     [PubMed]
Prasetyoputri A,Jarrad AM,Cooper MA,Blaskovich MAT, The Eagle Effect and Antibiotic-Induced Persistence: Two Sides of the Same Coin? Trends in microbiology. 2018 Nov 15     [PubMed]
Eggermont D,Smit MAM,Kwestroo GA,Verheij RA,Hek K,Kunst AE, The influence of gender concordance between general practitioner and patient on antibiotic prescribing for sore throat symptoms: a retrospective study. BMC family practice. 2018 Nov 17     [PubMed]
Bender JK,Cattoir V,Hegstad K,Sadowy E,Coque TM,Westh H,Hammerum AM,Schaffer K,Burns K,Murchan S,Novais C,Freitas AR,Peixe L,Del Grosso M,Pantosti A,Werner G, Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy. 2018 Nov 2     [PubMed]
Serio AW,Keepers T,Andrews L,Krause KM, Aminoglycoside Revival: Review of a Historically Important Class of Antimicrobials Undergoing Rejuvenation. EcoSal Plus. 2018 Nov     [PubMed]
Steffens E,Quintens C,Derdelinckx I,Peetermans WE,Van Eldere J,Spriet I,Schuermans A, Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates? Infection. 2018 Nov 15     [PubMed]
Aslam B,Wang W,Arshad MI,Khurshid M,Muzammil S,Rasool MH,Nisar MA,Alvi RF,Aslam MA,Qamar MU,Salamat MKF,Baloch Z, Antibiotic resistance: a rundown of a global crisis. Infection and drug resistance. 2018     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Pediatric-Infectious Diseases. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Pediatric-Infectious Diseases, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Pediatric-Infectious Diseases, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Pediatric-Infectious Diseases. When it is time for the Pediatric-Infectious Diseases board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Pediatric-Infectious Diseases.